Jump to content

Sumatriptan/naproxen

Add links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Colin (talk | contribs) at 23:01, 28 December 2020 (Removing claim not supported by the cited source per WP:NOR, WP:V and per WP:WEIGHT & WP:MEDMOS2020). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Sumatriptan/naproxen
Combination of
SumatriptanTriptan
Naproxen sodiumNSAID
Clinical data
Trade namesTreximet, Trexima, others
Routes of
administration		By mouth
Identifiers
KEGG

Sumatriptan/naproxen sodium, sold under the brand name Treximet, is a combination medication used to treat migraines attacks.[1] It is taken by mouth.[1]

Active ingredients

It combines 85 mg of sumatriptan, a selective 5-hydroxytryptamine1 (5-HT1) receptor subtype agonist and 500 mg of naproxen sodium, a member of the arylacetic acid group of nonsteroidal anti-inflammatory drugs (NSAIDs), in one tablet.

Side effects

Some of the listed side effects include dizziness, nausea, sleepiness, dry mouth, pain in neck, throat or jaw, numbness or tingling.[2]

References

  1. ^ a b "DailyMed - sumatriptan succinate and naproxen sodium tablet, film coated". dailymed.nlm.nih.gov. Retrieved 6 March 2019.
  2. ^ https://www.drugs.com/treximet.html
Retrieved from "https://en.wikipedia.org/w/index.php?title=Sumatriptan/naproxen&oldid=996855818"